HPTX

Hyperion Therapeutics, Inc. Press Releases

$29.55
*  
1.82
6.56%
Get HPTX Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading HPTX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Hyperion Therapeutics Observes Rare Disease Day 2015
2/27/2015 8:00:00 AM - GlobeNewswire


Hyperion Therapeutics Announces Fourth Quarter and Full Year 2014 Financial Results
2/26/2015 4:05:00 PM - GlobeNewswire


Hyperion Therapeutics to Present at the Cowen and Company 35th Annual Health Care Conference
2/25/2015 4:45:00 PM - GlobeNewswire


Hyperion Therapeutics to Report Fourth Quarter and Full Year 2014 Financial Results After Market on February 26, 2015
2/19/2015 4:00:00 PM - GlobeNewswire


Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Hyperion Therapeutics, Inc. Stockholders
2/18/2015 5:53:00 PM - Business Wire


Hyperion Therapeutics Enters Into Completion of Phase III Clinical Trial, Option and Mutual Release Agreement With Clal Biotechnology Industries and Yeda Research and Development Company
2/17/2015 1:00:00 AM - GlobeNewswire


Hyperion Therapeutics Initiates Clinical Study to Further Evaluate RAVICTI(R) in Pediatric Subjects Under Two Years of Age With Urea Cycle Disorders
2/10/2015 9:00:00 AM - GlobeNewswire


Hyperion Therapeutics to Present at the 2015 Leerink Global Healthcare Conference
2/4/2015 4:00:00 PM - GlobeNewswire


Hyperion Therapeutics Announces Data Published in Genetics in Medicine Showing Blood Ammonia and Glutamine as Predictors of Hyperammonemic Crises in Patients With Urea Cycle Disorders
1/12/2015 9:25:00 AM - GlobeNewswire


Hyperion Therapeutics Added to Nasdaq Biotechnology Index (NBI)
12/18/2014 4:05:00 PM - GlobeNewswire


Hyperion Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference
12/4/2014 4:05:00 PM - GlobeNewswire